The 4 M&A Due Diligence Gaps That Only Appear After Close

Diligence Without a Deal Thesis is Just a Checklist

Every acquisition has a thesis, AKA a specific answer to this question: What value are we capturing, and how does it get realized? Sometimes it's workforce integration on day one. Sometimes it's geographic expansion through a founder's relationships. Sometimes it's technology access that requires the acquired team to stay intact and execute. Sometimes it's regulatory arbitrage that depends on a clean close across three jurisdictions.

Whatever it is, the thesis determines what has to go right for the deal to work. That means it determines what your diligence needs to discover.

But most deal teams don't work that way. They run the same process (financial model, legal review, commercial diligence, IT assessment) regardless of what they're buying or why. The template gets applied, the boxes get checked, and the gaps that surface post-close are almost always in the areas the template never addressed.

Jann Lau, Head of M&A at Thoughtworks, put it directly in her M&A Science Podcast conversation on validating the deal thesis: 

Diligence needs to be anchored to the deal's core value drivers, not run as a parallel exercise that happens alongside the thesis rather than in service of it. The teams that get this right don't do more diligence. They scope it differently from the start.

The four gaps below aren't universal weaknesses. They're blind spots that surface when deal teams decouple diligence from the value they're trying to capture. Each one is predictable, avoidable, and maps directly to a deal thesis that wasn't driving the diligence process as it should have.

Labor and Employment Exposure: The Gap That Surfaces in Integration-Heavy Deals

When your deal thesis includes workforce consolidation, cost synergies, or facility rationalization, that thesis has a direct implication for your diligence scope. You need to know (before you sign) what it costs to execute the integration your thesis requires.

Most financial models account for headcount costs, but very few account for the cost of changing that headcount post-close.

In jurisdictions without employment-at-will, including most of Latin America, significant portions of Europe, and a growing number of Asia-Pacific markets, terminating employees without cause triggers statutory severance obligations. Those obligations are mandatory, jurisdiction-specific, and in some cases substantial enough to materially affect deal economics. If your integration plan includes a reduction in force, a facility closure, or a workforce consolidation across geographies, and you haven't modeled those costs by jurisdiction before LOI, you've scoped your diligence wrong for the deal you're running.

The same principle applies to collective bargaining agreements. If your closing conditions require operational changes at a unionized facility (a consolidation, a shutdown, a headcount reduction), you need union alignment before close. Not as a legal formality, but as a genuine relationship requirement. Attempting to execute a CBA-covered facility action without union buy-in is how deals get derailed by strikes and legal proceedings at the worst possible moment.

This isn't an exotic cross-border problem. It's a scoping problem. Evelyn De la Cruz, VP of People at Intercom, covered this directly in her M&A Science Podcast episode on employment exposure and thesis-specific diligence — ‍

The teams that handle this well connect their workforce decisions directly to their deal's business plan before close, not after.

What thesis-driven diligence looks like here:

• Model statutory severance exposure by jurisdiction for all employees at risk of post-close restructuring ( pre-LOI, not post-close)
• Identify collective bargaining agreements & the operational changes they govern
• Map the cost of every integration action your thesis requires against the employment law reality in each jurisdiction where you're operating
• If union alignment is a closing condition: Start that conversation early, in person, and treat it as a relationship requirement

Regulatory Timelines: The Gap That Surfaces in Cross-Border and Multi-Jurisdiction Deals

When your deal thesis includes closing across multiple jurisdictions, entering a new market, or acquiring a target with operations in countries that use consent-based regulatory systems, regulatory approval timelines aren’t a legal workstream; they’re a deal structure problem.

Most deal teams treat antitrust and regulatory review as something that happens after signing. You file the notice, observe the waiting period, and close when the clock runs out. That logic works in a notice-and-wait system, but it breaks down completely in a consent-based system where you can’t close until the regulator approves. And that approval can take three to nine months per jurisdiction.

The implication is more than a longer timeline. It's a fundamentally different deal structure. Multi-jurisdiction consent deals require staggered closings (closing in one country when that approval comes through, waiting on others). The SPA has to account for each closing separately, the integration plan has to account for operating in a partially closed state, and the deal economics have to account for the cost of time.

None of that complexity surfaces if regulatory diligence is treated as a checkbox rather than as a deal-structure input. Mark Legaspi, Senior Corporate Counsel at Zendesk, made this point in his M&A Science Podcast conversation on regulatory timing shapes deal structure — 

The current regulatory environment demands that teams build approval timelines into deal structure from day one, not retrofit the structure after the timeline becomes clear. That argument holds regardless of geography. 

In LATAM, it means consent regimes that can run for three to nine months per jurisdiction and staggered closings drafted into the SPA from the start. In Europe, it means something different but equally consequential. Mauro Sambati and Donato Romano covered the Italian version of this problem in their M&A Science Podcast episode on Golden Power and cross-border deal complexity, where regulatory review intersects with national-interest protections and jurisdiction-specific labor law in ways that a standard diligence template won’t capture. 

The geography changes, but the scoping failure is the same.

What thesis-driven diligence looks like here:

• Determine consent vs. notice-and-wait requirements in every jurisdiction where the target operates, before you model your closing timeline
• Build the longest plausible approval timeline into your deal structure, integration plan, and purchase agreement
• If multi-jurisdiction closings are required, draft staggered closing mechanics into the SPA from the start
• Engage local counsel with active regulator relationships (not just technical expertise) in every filing jurisdiction

Stakeholder Mapping: The Gap That Surfaces in Culturally-Dependent and Integration-Critical Deals

When your deal thesis is "we need this team to stay and execute" or "cultural fit is critical to value capture," your diligence scope needs to map every constituency whose cooperation you'll need post-close. 

Standard diligence maps equity holders, key employees with change-of-control clauses, and major customers. But it rarely maps the operational stakeholders like unions, local regulators, community relationships, founding family members, and senior managers without formal retention agreements. Their buy-in might not be contractually required, but it is operationally essential for the thesis to work.

The failure mode is consistent: the buyer assumes the legal mechanics are sufficient but discovers post-close (or worse, mid-close) that the human mechanics were the real closing condition all along.

This surfaces differently depending on deal type: 

• In a unionized industrial acquisition where your thesis requires facility rationalization, the union leader whose cooperation you need on day one is a stakeholder you should have mapped and engaged before signing.
• In a founder-led business where your thesis requires the founder's network and relationships to stay intact, the founder's unspoken conditions for post-close engagement are diligence items, not afterthoughts.
•  In a cross-border acquisition where community relationships underpin the target's operating license, those relationships are assets your thesis depends on (and they don't show up in the data room).

Cole Breidenbach, Head of Corporate Development at Domo, addressed the consequence of this gap directly in his M&A Science Podcast episode on leadership alignment and stakeholder coordination: 

Without early stakeholder alignment, deals close into confusion. Messaging fractures, retention suffers, and the integration execution your thesis depended on never materializes the way the model assumed it would.

What thesis-driven diligence looks like here:

• Map every constituency whose cooperation your thesis requires post-close — not just those with contractual obligations
• For each one: what do they need from this transaction, and what happens to your thesis if they don't cooperate
• Engage operational stakeholders (union leaders, key non-equity managers, community relationships) before close, not after
• If cultural fit is a value driver in your thesis, treat culture assessment as a diligence workstream with the same rigor as financial or legal review

Seller Dynamics: The Gap That Surfaces in Founder-Dependent and Relationship-Critical Deals

When your deal thesis is "this founder needs to stay and lead post-close" or "the seller's relationships are the asset we're buying," your diligence needs to go well beyond financials and representations.

Most deal teams treat the seller negotiation as a process to be optimized. But with founder and family sellers, that approach misses the actual deal. Price is rarely the only variable. With the sellers whose businesses are the product of decades of work — whose employees are people they know by name, whose legacy is wrapped up in what happens to the company after they leave — the non-price conditions often determine whether the deal closes and whether the thesis holds post-close.

What does this seller actually need from this transaction? What happens to their employees? Who runs the business? What does the company look like in five years? What role, if any, do they play after close? These aren't soft questions. They're diligence items. If you don't know the answers before you're in final negotiations, you're negotiating blind.

And if you retrade on price a week before signing — after months of negotiation, after the seller has mentally closed the deal — you're not just adjusting a number. You're signaling that you're not the right partner. The timing and framing of financial adjustments with founder and family sellers carries as much weight as the substance. A technically justified valuation adjustment raised at the wrong moment, in the wrong way, has killed deals that would have made everyone involved significantly wealthier.

It's a dynamic Isaac Lund, Managing Director at Generational Equity, broke down in his M&A Science Podcast conversation on working with private sellers — the emotional and relational dimensions of founder and family seller transactions aren't peripheral to the deal, they're central to whether the thesis holds post-close.

What thesis-driven diligence looks like here:

• Identify non-price seller priorities before price discussions begin — employee commitments, legacy, management continuity, post-close role
• Treat founder retention as a diligence workstream if your thesis depends on their continued involvement
• Surface any valuation concerns early — do not retrade in the final week before signing
• Document all non-price commitments in the SPA — verbal assurances don't survive close. 

Aligning Diligence to Your Deal Thesis

The fix isn't more diligence. It's diligence that's built around the deal you're actually running.

Four actions that change how this works in practice:

Define your deal thesis before you scope diligence. Not a high-level strategic rationale — a specific answer to: what value are we capturing, how does it get realized, and what has to go right for that to happen? If your team can't answer that question clearly before diligence begins, your diligence scope will default to last year's template.

Map the dependencies your thesis creates. Every thesis has a set of conditions that have to hold for it to work. Workforce integration requires labor diligence depth. Multi-jurisdiction close requires regulatory timeline mapping. Cultural execution requires stakeholder mapping. Founder retention requires seller dynamics diligence. The dependencies are knowable before you start. Build your scope around them.

Build diligence scope around those dependencies — not around a generic template. The template is a floor, not a ceiling. Use it as a starting point, then add the workstreams your thesis actually requires. As M&A Science's work on deal thesis validation and parallel planning for integration makes clear — integration planning should happen in parallel with diligence, not after it. The two processes inform each other. Running them sequentially is how thesis dependencies get missed.

Pressure-test diligence findings against your thesis — not against a checklist. When diligence surfaces a finding, the right question isn't "is this a material issue?" The right question is "does this affect what has to go right for our thesis to work?" Those are different questions. The second one is the one that catches the gaps that only show up after close.

The deal team that gets this right isn't working harder than the one that doesn't. They're asking different questions at the start of the process — and building their diligence scope around the answers.

If you're running diligence on a cross-border target and want to pressure-test your process against the gaps most teams miss, the Intelligence Hub has the LATAM Diligence Delta Checklist and the Latin America M&A Entry Playbook — plus an AI tutor trained on 400+ practitioner conversations you can run your current deal against.

[Access inside the Intelligence Hub — members only.]

‍